Risk of overestimation of non-pharmacologic treatment of hypertension?
Fagerberg, B.; Andersson, O.K.
Lakartidningen 86(10): 840
1989
ISSN/ISBN: 0023-7205 PMID: 2921893 Document Number: 329334
Document emailed within 1 workday
Related Documents
Krzesinski, J.M.; Rorive, G.L. 1987: When should pharmacologic treatment be instituted in hypertension? Revue Medicale de Liege 42(13-14): 644-649Rodríguez-Pérez, F.; Groszmann, R.J. 1992: Pharmacologic treatment of portal hypertension Gastroenterology Clinics of North America 21(1): 15-40
Svensson, T.; Sandlund, M.; Bygren, L.O. 1989: Good results after non-pharmacologic treatment of hypertension provided by health centers Lakartidningen 86(3): 124-126
Felizardo, A.; Maldonado, J.; Pego, M.; Teixeira, F.; Providência, L.A. 1997: Role of nitrates in pharmacologic modulation of reflected waves and their significance in the treatment of arterial hypertension in the elderly Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 16(7-8): 607
Stumpe, K.O.; Kolloch, R.; Overlack, A. 1977: Pharmacologic functional examination in arterial hypertension Der Internist 18(11): 594-600
Krulov, A.A.; Simonenko, M.G. 1987: Characteristics and pharmacologic prevention of cardiovascular system reactions in blood donors with borderline arterial hypertension Kardiologiia 27(8): 83-84
Rywik, S.; Kuźmińska, A.; Wagrowska, H.; Kurjata, P. 1990: Pharmacologic control of hypertension in the population of the right-bank Warsaw districts based on research from the Pol-Monica study Wiadomosci Lekarskie 43(1-2): 39-46
Suttle, N. 1993: Overestimation of copper deficiency Veterinary Record 133(5): 123-124
Youngleson, S.M. 1989: Overestimation of tuberculosis cure rates South African Medical Journal 75(5): 247
Xu, M.-g.; Sun, G.-x.; Zhou, Z.-y.; Li, J.-q.; Yu, R.-b.; Gu, D.-f. 2004: Assessment and analysis on the risk and community treatment of hypertension in rural areas in Changshu city Zhonghua Liu Xing Bing Xue Za Zhi 25(1): 33-35
Pieper, J.A. 2001: Pharmacologic interventions for coronary artery disease and risk factors. Introduction PharmacoTherapy 21(9 Pt 2): 189S
Costa, F.V. 1988: Clinical pharmacologic aspects of mepartricin. Possible pharmacologic interference with digitaloids and anticoagulants Minerva Urologica e Nefrologica 40(2 Suppl): 5-6
Sleptsova, S.I. 1987: Effects of various pharmacologic and non-pharmacologic agents on the mother and fetus (data for the health promotion propaganda) Akusherstvo i Ginekologiia 12: 68-71
Volkov, V.S.; Tsikulin, A.E. 1986: Various factors in the risk of developing hypertension in persons with borderline arterial hypertension Klinicheskaia Meditsina 64(7): 107-110
Gram, J.; Munkvad, S.; Jespersen, J. 1989: Elevated plasma concentrations of fibrinogen may cause an overestimation of functional plasminogen Thrombosis and Haemostasis 61(1): 154
Burakovskiĭ, V.I.; Bukharin, V.A.; Plotnikova, L.R.; Faĭnberg, M.A. 1971: Pharmacologic tests for evaluation of the state of the pulmonary vessels in patients with congenital heart defects and severe pulmonary hypertension Kardiologiia 11(4): 25-33
Johannesson, M.; Borgqvist, L.; Jönsson, B.; Råstam, L. 1991: Treatment of hypertension in Sweden: treatment of patients with hypertension costs more than a billion crowns per year Lakartidningen 88(12): 1103-1106
Trumbo, P.R.; Ellwood, K.C. 2007: Supplemental calcium and risk reduction of hypertension, pregnancy-induced hypertension, and preeclampsia: an evidence-based review by the US Food and Drug Administration Nutrition Reviews 65(2): 78-87
Hemmelgarn, B.R.; Zarnke, K.B.; Campbell, N.R.C.; Feldman, R.D.; McKay, D.W.; McAlister, F.A.; Khan, N.; Schiffrin, E.L.; Myers, M.G.; Bolli, P.; Honos, G.; Lebel, M.; Levine, M.; Padwal, R. 2004: The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk Canadian Journal of Cardiology 20(1): 31-40
Qasim, A.; Bashir, A.; Sajid, S.; Riaz, M.M.; Almas, A. 2016: Women with pregnancy induced hypertension have a higher risk of developing essential hypertension - a case control study from a tertiary care center in Pakistan JPMA. Journal of the Pakistan Medical Association 66(2): 179-183